New PKU drug enters first human safety testing
NCT ID NCT07241234
Summary
This is an early safety study for a new oral drug called AG-181 in adults with phenylketonuria (PKU). The main goal is to see if the drug is safe and well-tolerated in 20 participants. Researchers will also measure how the drug moves through the body and its effect on blood phenylalanine levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.